BR112017008709A2 - tratamento ou prevenção da anemia em mamíferos não-humanos grávidos - Google Patents
tratamento ou prevenção da anemia em mamíferos não-humanos grávidosInfo
- Publication number
- BR112017008709A2 BR112017008709A2 BR112017008709A BR112017008709A BR112017008709A2 BR 112017008709 A2 BR112017008709 A2 BR 112017008709A2 BR 112017008709 A BR112017008709 A BR 112017008709A BR 112017008709 A BR112017008709 A BR 112017008709A BR 112017008709 A2 BR112017008709 A2 BR 112017008709A2
- Authority
- BR
- Brazil
- Prior art keywords
- pregnant non
- human mammal
- anemia
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
resumo "tratamento ou prevenção da anemia em mamíferos não-humanos grávidos" a presente invenção refere-se a um complexo de carboidratos de ferro para uso em um método para aumentar a concentração de hemoglobina no sangue em um mamífero não-humano grávido, em que a um mamífero não-humano grávido com um nível de hemoglobina no sangue de 105 g / l ou menos é administrada uma ou mais doses do complexo de carboidrato de ferro ao qual compreende uma quantidade de ferro elementar de 1800 mg ou mais por dose. o método refere-se aos efeitos adicionais de diminuir a taxa de nascidos mortos de um mamífero não-humano grávido com um nível de hemoglobina no sangue de 105 g / l ou menos, aumentando a concentração de hemoglobina no sangue de ninhadas das crias no prazo de 3 dias após o nascimento e / ou desma-me, ou aumentando o tamanho da ninhada em uma paridade subsequente de um mamífero não-humano com um nível de hemoglobina no sangue de 105 g / l ou menos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201470654 | 2014-10-27 | ||
| PCT/DK2015/050328 WO2016066172A1 (en) | 2014-10-27 | 2015-10-27 | Treatment or prevention of anaemia in pregnant non-human mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017008709A2 true BR112017008709A2 (pt) | 2017-12-26 |
Family
ID=54360839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017008709A BR112017008709A2 (pt) | 2014-10-27 | 2015-10-27 | tratamento ou prevenção da anemia em mamíferos não-humanos grávidos |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11040059B2 (pt) |
| EP (2) | EP3603632A1 (pt) |
| JP (1) | JP6680777B2 (pt) |
| CN (3) | CN113559115A (pt) |
| BR (1) | BR112017008709A2 (pt) |
| CA (1) | CA2965722C (pt) |
| DK (1) | DK3212182T3 (pt) |
| ES (1) | ES2743223T3 (pt) |
| HU (1) | HUE045092T2 (pt) |
| LT (1) | LT3212182T (pt) |
| MX (1) | MX2017005419A (pt) |
| PH (1) | PH12017500646A1 (pt) |
| PL (1) | PL3212182T3 (pt) |
| PT (1) | PT3212182T (pt) |
| RS (1) | RS59240B1 (pt) |
| RU (1) | RU2712211C2 (pt) |
| WO (1) | WO2016066172A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3212182T (lt) * | 2014-10-27 | 2019-10-10 | Pharmacosmos Holding A/S | Anemijos gydymas arba prevencija nėščiuose ne žmogaus žinduoliuose ir palikuonyse |
| WO2018005913A1 (en) * | 2016-06-30 | 2018-01-04 | Vonnahme Kimberly A | Method for improving the quality and quantity of offspring in mammals |
| EP3681539A1 (en) | 2017-09-11 | 2020-07-22 | Pharmacosmos Holding A/S | Iron complex compounds for therapeutic use |
| WO2020089227A1 (en) * | 2018-10-29 | 2020-05-07 | Pharmacosmos Holding A/S | Treating iron deficiency with ferric carboxymaltose |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105791A (en) * | 1961-07-20 | 1963-10-01 | Richardson Merrell Inc | Method of preventing the development of iron deficiency anemia in suckling pigs |
| US3259500A (en) * | 1961-10-11 | 1966-07-05 | Kentucky Res Foundation | Method for inhibiting anemia in young pigs by feeding the sow an iron agent |
| US4076803A (en) | 1976-03-15 | 1978-02-28 | Ashmead H H | Synergistic combination of metal proteinates with beta-chlorovinyl dialkyl phosphates |
| DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| WO2002085134A1 (en) * | 2001-04-24 | 2002-10-31 | Lonza Ltd. | Method of enhancing reproductive performance in sows |
| RU2274003C2 (ru) | 2004-03-02 | 2006-04-20 | Станислав Людвигович Люблинский | Способ комплексной переработки крови сельскохозяйственных животных для получения биологически активного вещества с противоанемическими свойствами на основе гемоглобина, биологически активное вещество с противоанемическими свойствами (варианты) и продукт, его содержащий (варианты). |
| DE102007054794A1 (de) | 2007-11-13 | 2009-05-14 | Agilan Gmbh | Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen |
| PL3156075T3 (pl) * | 2009-03-25 | 2021-04-19 | Pharmacosmos Holding A/S | Oligosacharyd i sposób jego wytwarzania |
| DK2675475T3 (en) | 2011-02-17 | 2015-09-14 | Boehringer Ingelheim Vetmed | NEW EUROPEAN PRRSV TRIAL |
| LT3212182T (lt) * | 2014-10-27 | 2019-10-10 | Pharmacosmos Holding A/S | Anemijos gydymas arba prevencija nėščiuose ne žmogaus žinduoliuose ir palikuonyse |
-
2015
- 2015-10-27 LT LTEP15787128.6T patent/LT3212182T/lt unknown
- 2015-10-27 BR BR112017008709A patent/BR112017008709A2/pt not_active Application Discontinuation
- 2015-10-27 RS RSP20190966 patent/RS59240B1/sr unknown
- 2015-10-27 DK DK15787128.6T patent/DK3212182T3/da active
- 2015-10-27 EP EP19181718.8A patent/EP3603632A1/en active Pending
- 2015-10-27 MX MX2017005419A patent/MX2017005419A/es active IP Right Grant
- 2015-10-27 CN CN202110410139.3A patent/CN113559115A/zh active Pending
- 2015-10-27 CA CA2965722A patent/CA2965722C/en active Active
- 2015-10-27 JP JP2017522471A patent/JP6680777B2/ja active Active
- 2015-10-27 ES ES15787128T patent/ES2743223T3/es active Active
- 2015-10-27 CN CN201580058214.7A patent/CN107206017B/zh active Active
- 2015-10-27 RU RU2017118319A patent/RU2712211C2/ru active
- 2015-10-27 HU HUE15787128A patent/HUE045092T2/hu unknown
- 2015-10-27 CN CN202110407403.8A patent/CN113476471A/zh active Pending
- 2015-10-27 US US15/522,466 patent/US11040059B2/en active Active
- 2015-10-27 EP EP15787128.6A patent/EP3212182B1/en active Active
- 2015-10-27 WO PCT/DK2015/050328 patent/WO2016066172A1/en active Application Filing
- 2015-10-27 PT PT15787128T patent/PT3212182T/pt unknown
- 2015-10-27 PL PL15787128T patent/PL3212182T3/pl unknown
-
2017
- 2017-04-06 PH PH12017500646A patent/PH12017500646A1/en unknown
-
2021
- 2021-03-15 US US17/201,110 patent/US20210369763A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017118319A3 (pt) | 2019-06-17 |
| CN107206017B (zh) | 2021-05-07 |
| CN113476471A (zh) | 2021-10-08 |
| CA2965722A1 (en) | 2016-05-06 |
| DK3212182T3 (da) | 2019-08-05 |
| RU2712211C2 (ru) | 2020-01-27 |
| RS59240B1 (sr) | 2019-10-31 |
| EP3212182B1 (en) | 2019-06-26 |
| PL3212182T3 (pl) | 2019-12-31 |
| US20210369763A1 (en) | 2021-12-02 |
| CN113559115A (zh) | 2021-10-29 |
| EP3603632A1 (en) | 2020-02-05 |
| WO2016066172A1 (en) | 2016-05-06 |
| EP3212182A1 (en) | 2017-09-06 |
| PH12017500646A1 (en) | 2017-09-25 |
| JP2017535537A (ja) | 2017-11-30 |
| CA2965722C (en) | 2023-02-14 |
| MX2017005419A (es) | 2017-11-30 |
| PT3212182T (pt) | 2019-07-29 |
| ES2743223T3 (es) | 2020-02-18 |
| US20170333470A1 (en) | 2017-11-23 |
| LT3212182T (lt) | 2019-10-10 |
| RU2017118319A (ru) | 2018-11-29 |
| JP6680777B2 (ja) | 2020-04-15 |
| CN107206017A (zh) | 2017-09-26 |
| US11040059B2 (en) | 2021-06-22 |
| HUE045092T2 (hu) | 2019-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017008709A2 (pt) | tratamento ou prevenção da anemia em mamíferos não-humanos grávidos | |
| AR097178A1 (es) | Diagnóstico y terapias anticáncer que comprenden células madre cancerosas | |
| BR112015026095A2 (pt) | métodos para controlar a dosagem de uma droga antitumoral administrada a um paciente com câncer, para administração de pelo menos uma droga antitumoral em duas doses separadas em um paciente com câncer e para seleção de pelo menos uma droga antitumoral | |
| BR112019005930A2 (pt) | combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas | |
| BR112019008762A2 (pt) | método para o tratamento de um distúrbio proliferativo mutado em flt3 | |
| EA201590655A8 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
| BR112018003232A2 (pt) | terapias de combinação para tratamento de câncer | |
| CL2019001214A1 (es) | Composición farmacéutica, métodos para tratamiento y sus usos. | |
| BR112019009256A2 (pt) | métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo | |
| BR112018006445A2 (pt) | métodos para tratar distrofia muscular | |
| BR112018076639A2 (pt) | quimioterapias de combinação | |
| BR112017006272A2 (pt) | composição farmacêutica para tratar colite ulcerativa. | |
| BR112015010039A2 (pt) | tratamento de câncer com pomalidomida em um individuo com disfunção renal | |
| BR112016026545A8 (pt) | eribulina ou um sal farmaceuticamente aceitável do mesmo, seus usos e kit para utilização no tratamento de câncer da mama | |
| MX2016014346A (es) | Tratamiento de enfermedad de crohn con 6-mercaptopurina de liberacion prolongada. | |
| BR112017027378A2 (pt) | linhagem atenuada de salmonella e composição farmacêutica | |
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
| JP2016519107A5 (pt) | ||
| BR112016016932A2 (pt) | Tratamento de neoplasia | |
| BR112015020566A2 (pt) | moduladres de ror gama | |
| Carpenter | Bruising: case report | |
| Yoshida | Bevacizumab/carboplatin/paclitaxel | |
| BR112017017608A2 (pt) | métodos para tratamento de esquizofrenia ou um sintoma de esquizofrenia, para prevenir uma recaída esquizofrênica e para manter o efeito de iloperidona para esquizofrenia. | |
| Santos et al. | Extended darbepoetin alfa dosing apparently reduced erythropoiesis stimulating agent requirement to achieve haemoglobin target | |
| Vidyendaran | Modafinil abuse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B154 | Notification of filing of divisional application [chapter 15.50 patent gazette] |
Free format text: O PEDIDO FOI DIVIDIDO NO BR122023013824-4 PROTOCOLO 870230060439 EM 10/07/2023 21:03. |
|
| B09R | Decision of refusal: republication [chapter 9.2.3 patent gazette] |
Free format text: REPUBLICACAO INDEFERIMENTO DA RPI 2743. |